Gsa Capital Partners LLP Biora Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.13 - $12.03 $166,031 - $15.4 Million
1,277,165 Added 157.22%
2,089,502 $275,000
Q3 2022

Nov 14, 2022
BUY
$0.53 - $13.3 $430,538 - $10.8 Million
812,337 New
812,337 $394,000
Q1 2022

May 11, 2022
SELL
$1.11 - $2.25 $57,572 - $116,700
-51,867 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$1.35 - $4.89 $760,313 - $2.75 Million
-563,195 Reduced 91.57%
51,867 $108,000
Q3 2021

Nov 12, 2021
BUY
$0.67 - $3.41 $412,091 - $2.1 Million
615,062 New
615,062 $935,000

Others Institutions Holding BIOR

# of Institutions
2
Shares Held
890
Call Options Held
0
Put Options Held
0
View Full List

About BIORA THERAPEUTICS, INC.

BIOR Quotes by TradingView
  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $312M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email